Biochemical Hepatic Changes in Chronic Hepatitis C Patients Induced by Sofosbuvir and Daclatasvir with or without Ribavirin Regimens

EFFECTS OF SOFOSBUVIR AND RIBAVIRIN ON SOME HAEMATOLOGICAL AND BIOCHEMICAL PARAMETERS IN NORMAL RATS

Safety and Efficacy of Ombitasvir, Paritaprevirand Ritonavir Combination with Ribavirin for Treatment of Chronic Hepatitis C Virus in Advanced Kidney Diseases Patients in Upper E

Sofosbuvir plus Ribavirin for Treatment-Naïve Chronic HCV Genotype 4 Patients: Real-life Experience

Efficacy of Sofosbuvir plus Daclatasvir in Treatment of Chronic HCV Infection in Egyptian Patients: A Prospective Cohort Study

Safety & Efficacy of Direct Acting Antiviral (Sofosbuvir & Daclatasvir) in Treatment of Chronic HCV in HIV-HCV Co-Infected Egyptian Patients

EFFICACY OF SOFOSBUVIR, DACLAVIR AND RIBAVIRIN IN TREATMENT OF HCV INFECTION WITH DIFFERENT STAGES OF LIVER DISEASE

Efficacy and Safety of Generic (Velpatasvir containing regimen) among Adult Chronic HCV Patients Non-responders to Treatment by Sofosbuvir Plus Daclatasvir Regimen in Egypt

Efficacy and Adverse Effects of Sofosbuvir plus Daclatasvir Therapy in Chronic HCV Patients in Sharkia Governorate, Egypt

Comparative Study between Triple Therapy (Peginterferon /Ribavirin/Sofosbuvir) and Dual Therapy (Simeprevir /Sofosbuvir) in Treatment of Chronic HCV Patients